Finzati - Logo
KPRX logo

Kiora Pharmaceuticals, Inc.

KPRX • Biotechnology
$2.35
▲ +0.02 (+0.86%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$14.52M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Manageable debt level · 0.02Healthy liquidity · 5.99Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 9, 2026, 12:17 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$2.35
Change0.86%
Shares Out6.18M
Market Cap$14.52M
Enterprise Value$-1.99M
52W Range1.76 - 3.01
Beta-0.39
P/E-1.32
P/B0.86
P/FCF-1.69
EV/EBITDA0.19
EV/FCF0.23

Investment DNA

How strong this company looks for long-term investors

51
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.02Healthy liquidity · 5.99Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 2/13/2015
Industry: Biotechnology
P/B i: 0.86
Debt / Equity i: 0.02
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.02
Current Ratio: 5.99
Quick Ratio: 5.99
Status: Good

Insider Transactions

Recent executive and insider activity

Strem Brian M.
Transaction: 07/01/2026
SELL
Change
-1,869
Price
$2.66
Filing
07/02/2026
Type
SELL
Tosca Melissa
Transaction: 07/01/2026
SELL
Change
-911
Price
$2.66
Filing
07/02/2026
Type
SELL
TYLE PRAVEEN
Transaction: 06/10/2026
BUY
Change
+40,000
Price
$2.63
Filing
06/12/2026
Type
BUY